Stock Market Reviews

Read and share opinions on VEEV (Veeva Systems Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
  Dec 29, 2025
• Are Options Traders Betting on a Big Move in Veeva Systems Stock?
  Dec 23, 2025
• Weighing Veeva Systems Valuation After Choppy 2025 Performance and DCF Upside Potential
  Dec 23, 2025
• Is CRM Competition Quietly Reshaping Veeva Systems’ (VEEV) Core Commercial Moat?
  Dec 23, 2025
• Stifel Maintains Buy on Veeva (VEEV) Despite CRM Customer Migrations
  Dec 22, 2025
• Assessing Veeva Systems (VEEV) Valuation After a Recent Share Price Pullback
  Dec 11, 2025
• Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock
  Dec 11, 2025
• Jim Cramer on Veeva: “Let’s Stay Away”
  Dec 11, 2025
• Veeva Systems Inc. (VEEV): A Bull Case Theory
  Dec 9, 2025
• Why Veeva Systems (VEEV) Shares Are Sliding Today
  Dec 9, 2025
• Time for (Selective) Caution in Tech. 3 Stocks With Bearish Charts.
  Dec 8, 2025
• Is Veeva Systems Fairly Priced After Recent 17.4% Pullback and DCF Upside?
  Dec 5, 2025
• Veeva to Present at Upcoming Investor Conference
  Dec 4, 2025
• Veeva AI Agents Now Available to Increase Productivity and Customer Centricity
  Dec 4, 2025

VEEV News

• Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
  VEEV's strong Q3, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.
  Dec 29, 2025
• Are Options Traders Betting on a Big Move in Veeva Systems Stock?
  Investors need to pay close attention to VEEV stock based on the movements in the options market lately.
  Dec 23, 2025
• Is CRM Competition Quietly Reshaping Veeva Systems’ (VEEV) Core Commercial Moat?
  In December 2025, Veeva Systems’ board appointed longtime finance leader Vipin Kondath as principal accounting officer, formalizing his oversight of the company’s financial reporting and controls without altering his compensation terms. At the same time, contrasting analyst views on rising CRM competition and pharma client migrations highlighted growing scrutiny of Veeva’s core commercial platform. We’ll now examine how concerns about CRM competition and pharma client migrations may...
  Dec 23, 2025
• Weighing Veeva Systems Valuation After Choppy 2025 Performance and DCF Upside Potential
  If you are wondering whether Veeva Systems is actually worth its premium price tag, or if there is still upside left in the story, you are not alone. This breakdown is intended to help you cut through the noise. The stock has been choppy lately, up around 1.5% over the last week but still down roughly 8.5% over the past month. This leaves year to date returns at about 6.1% and close to flat over the last year. Recent headlines have focused on Veeva's continued expansion across life sciences...
  Dec 23, 2025
• Stifel Maintains Buy on Veeva (VEEV) Despite CRM Customer Migrations
  Veeva Systems Inc. (NYSE:VEEV) is one of the best healthcare AI stocks to buy now. On December 15, Stifel reiterated a Buy rating on Veeva Systems Inc. (NYSE:VEEV), even as some big pharmaceutical customers shift away from its legacy CRM platform. Stifel sees these migrations as a small, manageable issue that won’t derail Veeva’s overall […]
  Dec 22, 2025
• DigitalOcean, Veeva Systems, and Teradata Shares Are Soaring, What You Need To Know
  A number of stocks jumped in the afternoon session after investor optimism around artificial intelligence fueled broad market gains.
  Dec 19, 2025
• 1 Profitable Stock to Keep an Eye On and 2 We Question
  While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
  Dec 18, 2025
• Roblox downgraded, Lululemon upgraded: Wall Street's top analyst calls
  Roblox downgraded, Lululemon upgraded: Wall Street's top analyst calls
  Dec 12, 2025
• Jim Cramer on Veeva: “Let’s Stay Away”
  Veeva Systems Inc. (NYSE:VEEV) is one of the stocks Jim Cramer recently commented on. During the episode, a caller asked for Cramer’s thoughts on the stock, and he said: “Okay, it’s very controversial because what’s happened is that it was knocked several times in the Salesforce call. Salesforce was very successful. It makes me feel […]
  Dec 11, 2025
• Here is What to Know Beyond Why Veeva Systems Inc. (VEEV) is a Trending Stock
  Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
  Dec 11, 2025
• Assessing Veeva Systems (VEEV) Valuation After a Recent Share Price Pullback
  Veeva Systems (VEEV) has drifted lower over the past month, even as revenue and net income continue to grow at double digit rates. That disconnect is exactly what has value focused investors paying closer attention. See our latest analysis for Veeva Systems. Despite that fundamental strength, sentiment has cooled lately, with a roughly 22.5 percent 1 month share price return pulling back from earlier gains, even though the 3 year total shareholder return near 30 percent still signals a solid...
  Dec 11, 2025
• Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition?
  Tempus AI's shift toward scalable revenues, high-margin data services and broader AI capabilities defines a pivotal moment for TEM investors.
  Dec 10, 2025
• Veeva Systems Inc. (VEEV): A Bull Case Theory
  We came across a bullish thesis on Veeva Systems Inc. on Compound & Fire’s Substack by Compound & Fire. In this article, we will summarize the bulls’ thesis on VEEV. Veeva Systems Inc.’s share was trading at $240.14 as of December 2nd. VEEV’s trailing and forward P/E were 46.86 and 27.86 respectively according to Yahoo Finance. Veeva Systems […]
  Dec 9, 2025
• Why Veeva Systems (VEEV) Shares Are Sliding Today
  Shares of life sciences cloud software provider Veeva Systems (NYSE:VEEV) fell 3% in the morning session after a lack of positive news catalysts allowed technical trading patterns to dominate, continuing its recent underperformance. According to technical analysis, the stock's recent price behavior had been difficult. Its technical rating was poor, with negative trends observed in both the short and long term. The stock also underperformed the wider S&P 500 index over recent months. This downwar
  Dec 9, 2025
• Time for (Selective) Caution in Tech. 3 Stocks With Bearish Charts.
  Several widely held tech stocks have failed to keep pace with the group’s rally, a divergence investors should treat with caution. Not all software stocks are dropping, as standout performers AppLovin MongoDB and CrowdStrike Holdings have each rallied more than 20% over the last three months, highlighting how uneven the group has become. One name that appears on shaky footing is Veeva Systems a cloud-based software company focused on healthcare.
  Dec 8, 2025
• Is Veeva Systems Fairly Priced After Recent 17.4% Pullback and DCF Upside?
  Wondering if Veeva Systems is still a smart buy at today’s price, or if the easy gains are already behind it? This article breaks down what the current share price really implies about future value. After a choppy few weeks where the stock slipped 17.4% over the last month but remains up 15.1% year to date and 40.0% over three years, investors are trying to work out whether this is a healthy pause or the start of a rerating. Recent headlines have focused on Veeva’s continued push deeper into...
  Dec 5, 2025
• Veeva AI Agents Now Available to Increase Productivity and Customer Centricity
  In a major milestone for Veeva AI, industry-specific AI for life sciences, Veeva Systems (NYSE: VEEV) today announced the availability of Veeva AI Agents for Vault CRM and PromoMats. Veeva AI in the Veeva Vault Platform and deep, specialized AI agents working in Veeva applications deliver practical AI with clear business value. Additional Veeva AI Agents for clinical, regulatory, safety, quality, medical, and commercial are planned for release throughout 2026.
  Dec 4, 2025
• Veeva to Present at Upcoming Investor Conference
  Veeva Systems (NYSE: VEEV) today announced participation in the following investor conference:
  Dec 4, 2025
• Veeva AI Agents Now Available to Increase Productivity and Customer Centricity
  In a major milestone for Veeva AI, industry-specific AI for life sciences, Veeva Systems (NYSE: VEEV) today announced the availability of Veeva AI Agents for Vault CRM and PromoMats. Veeva AI in the Veeva Vault Platform and deep, specialized AI agents working in Veeva applications deliver practical AI with clear business value. Additional Veeva AI Agents for clinical, regulatory, safety, quality, medical, and commercial are planned for release throughout 2026.
  Dec 3, 2025
• 3 Cash-Producing Stocks Worth Your Attention
  Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain momentum.
  Dec 2, 2025
• 2 Growth Stocks With More Room to Run to Buy Ahead of 2026
  Some investors are jumping ship. Here's why you shouldn't.
  Dec 2, 2025
• Returns On Capital Signal Tricky Times Ahead For Veeva Systems (NYSE:VEEV)
  Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
  Nov 28, 2025
• Veeva Systems Inc. (VEEV) is Attracting Investor Attention: Here is What You Should Know
  Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
  Nov 27, 2025
• US Stock Market Today: S&P 500 Futures Rise as Rate Cut Hopes Lift Sentiment
  The Morning Bull - US Market Morning Update Monday, Nov, 24 2025 US stock futures are climbing this morning, with the main index up around 0.7% before the opening bell. The latest signal comes from a closely-watched confidence survey showing Americans are still feeling down about the economy, with November’s reading stuck near historic lows at just 51.0. That tells us people are worried about the cost of living and stretching their paychecks. However, expectations for inflation next year...
  Nov 24, 2025
• Veeva Announces Expanded Partnership with Roche
  Veeva Systems (NYSE: VEEV) today announced that Roche Pharmaceuticals has chosen to extend its partnership with Veeva Systems by adopting Veeva Vault CRM.
  Nov 24, 2025
• Veeva (VEEV) International Revenue Performance Explored
  Examine the evolution of Veeva's (VEEV) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
  Nov 24, 2025
• Veeva Systems (VEEV): Evaluating Valuation After Strong Q3 Results and Upbeat AI-Driven Guidance
  Veeva Systems (VEEV) delivered strong third-quarter results, beating revenue and earnings estimates while sharing an upbeat outlook for the rest of the fiscal year. The company is highlighting continued strength in its core software operations and growing adoption of Veeva AI. See our latest analysis for Veeva Systems. Despite impressive third-quarter results and upbeat new guidance, Veeva Systems’ share price took a sharp hit, falling nearly 10% in a single day, as investor jitters about...
  Nov 23, 2025
• Veeva Systems (VEEV) Rises on Upbeat Guidance and AI Momentum – What Does It Mean for the Outlook?
  Veeva Systems reported third-quarter revenue of US$811.24 million and net income of US$236.2 million, both above prior-year results, and raised its guidance for fiscal 2026 revenue to between US$3.17 billion and US$3.17 billion. A distinct highlight was the company's emphasis on advancing Veeva AI, which is already delivering practical benefits and supporting targeted innovation across core product lines. We'll now assess how Veeva's raised guidance and rapid AI progress may influence the...
  Nov 22, 2025
• VEEV Q3 Deep Dive: CRM Transitions and AI Progress Shape Mixed Market Response
  Life sciences cloud software provider Veeva Systems (NYSE:VEEV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 16% year on year to $811.2 million. Guidance for next quarter’s revenue was better than expected at $808.5 million at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $2.04 per share was 4.5% above analysts’ consensus estimates.
  Nov 21, 2025
• Veeva Systems Inc (VEEV) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
  Veeva Systems Inc (VEEV) reports impressive Q3 results with $811 million in revenue, while navigating CRM market shifts and leveraging AI for future growth.
  Nov 21, 2025
• Why Veeva Systems (VEEV) Shares Are Trading Lower Today
  Shares of life sciences cloud software provider Veeva Systems (NYSE:VEEV) fell 10.6% in the afternoon session after the company reported third-quarter results that beat Wall Street's expectations, but the market seemingly hoped for more, focusing on a potential slowdown in future growth.
  Nov 21, 2025
• Top Midday Stories: Lilly Becomes First Pharma Company to Hit $1 Trillion Market Cap; Enviri to Sell Clean Earth to Veolia for $3.04 Billion
  The major US stock indexes were up in late-morning trading Friday as investors remained concerned ov
  Nov 21, 2025
• Veeva Systems Stock Down Despite Q3 Earnings & Revenues Top Estimates
  VEEV posts a Q3 earnings beat with stronger subscription growth and higher full-year guidance, highlighting continued momentum.
  Nov 21, 2025
• Is Veeva Systems Fairly Priced After Recent Product Launches and Stock Pullback in 2025?
  Wondering if Veeva Systems is still worth your investment dollars? You're not alone, especially with this stock closely watched by investors looking for value and growth. While Veeva’s share price is up a strong 28.5% year-to-date and 26.1% over the past year, recent weeks have seen a pullback with the stock down 7.3% in the last week and 6.7% over the past month. Several high-profile partnerships and product launches have kept Veeva in the spotlight, generating optimism about its future...
  Nov 21, 2025
• Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023.
  Veeva Systems raised its full-year outlook for the third quarter in a row but shares were sliding Friday as one detail from the earnings call overshadowed the software company’s quarterly results. Shares slumped more than 10% after Veeva said it expected to end up with just 14 of the largest 20 biopharmaceutical companies as Vault CRM customers, versus previous higher expectations, with rival Salesforce securing the other six. Veeva broke off its partnership with Salesforce in 2022 and released Vault CRM, its customer relationship management platform, two years later to replace software it had built using Salesforce technology.
  Nov 21, 2025
• Stock Market Today: Dow Gains Nearly 500 Points After Whipsaw Action As Nvidia Finishes Lower (Live Coverage)
  Stock Market Today: The Dow Jones index rallied Friday after back-and-forth action. But Nvidia and Palantir couldn't pull ahead.
  Nov 21, 2025
• Stocks to Watch Friday Recap: Eli Lilly, Intuit, Gap, Warner Bros.
  ↗️ Eli Lilly (LLY): The drugmaker became the first pharmaceutical company to hit a $1 trillion market capitalization. It ended the day with a market cap of $1.002 trillion after the stock rose 1.6%. Booming demand for its weight-loss drugs has boosted shares.
  Nov 21, 2025
• Stocks Rise Pre-Bell as Traders Parse Nvidia's Earnings, Await September Jobs Report
  US equity markets were tracking in the green before the opening bell Thursday as investors assess te
  Nov 20, 2025
• Veeva Systems (NYSE:VEEV) Beats Q3 CY2025 Sales Expectations
  Life sciences cloud software provider Veeva Systems (NYSE:VEEV) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 16% year on year to $811.2 million. Guidance for next quarter’s revenue was better than expected at $808.5 million at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $2.04 per share was 4.5% above analysts’ consensus estimates.
  Nov 20, 2025
• Veeva Systems (VEEV) Surpasses Q3 Earnings and Revenue Estimates
  Veeva (VEEV) delivered earnings and revenue surprises of +4.62% and +2.44%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 20, 2025
• Compared to Estimates, Veeva (VEEV) Q3 Earnings: A Look at Key Metrics
  The headline numbers for Veeva (VEEV) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
  Nov 20, 2025
• Veeva Announces Fiscal 2026 Third Quarter Results
  Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2025.
  Nov 20, 2025
• Veeva: Fiscal Q3 Earnings Snapshot
  VEEV) on Thursday reported fiscal third-quarter net income of $236.2 million. On a per-share basis, the Pleasanton, California-based company said it had net income of $1.40. Earnings, adjusted for one-time gains and costs, came to $2.04 per share.
  Nov 20, 2025
• Veeva Systems beats Q3 expectations, raises full-year outlook
  Investing.com -- Veeva Systems Inc (NYSE:VEEV) reported third-quarter fiscal 2026 results that exceeded analyst expectations, with the cloud software provider raising its full-year guidance as it continues to expand its AI capabilities and development cloud offerings.
  Nov 20, 2025
• Equities Fall Intraday as Markets Weigh Jobs Data; Nvidia Drops
  US benchmark equity indexes were lower intraday as a long-awaited labor market report showed the une
  Nov 20, 2025
• Veeva Systems (VEEV) Q3 Earnings Report Preview: What To Look For
  Life sciences cloud software provider Veeva Systems (NYSE:VEEV) will be reporting results this Thursday after market hours. Here’s what to look for.
  Nov 19, 2025
• Veeva (VEEV) Is Considered a Good Investment by Brokers: Is That True?
  According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
  Nov 18, 2025
• $9.85 Bn Pharma And Biotech CRM Software Global Market Opportunities And Strategies To 2034: Top 10 Players Control 94.96% of 2023 Market, Led by Veeva Systems at 26.81% Share
  The pharma and biotech CRM software market presents key growth opportunities in AI-driven CRMs and cloud-based solutions, particularly for SMEs, pharma industries, and emerging markets like Asia Pacific. Strategies focusing on AI integration, strategic partnerships, and multichannel networks can maximize growth potential. Global Pharma And Biotech CRM Software Market Global Pharma And Biotech CRM Software Market Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "Pharma And Biotech CRM Software Globa
  Nov 17, 2025
• Unveiling Veeva (VEEV) Q3 Outlook: Wall Street Estimates for Key Metrics
  Besides Wall Street's top-and-bottom-line estimates for Veeva (VEEV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended October 2025.
  Nov 17, 2025
• Is Veeva Systems Inc.'s (NYSE:VEEV) Recent Performance Tethered To Its Attractive Financial Prospects?
  Veeva Systems' (NYSE:VEEV) stock is up by 4.0% over the past three months. Since the market usually pay for a company’s...
  Nov 16, 2025
• Veeva Expands Basics Suite as Over 100 Biotechs Adopt Platform for Scalable Growth
  Veeva Systems Inc. (NYSE:VEEV) is one of the best digital health stocks to buy now. On November 4, 2025, Veeva announced that its Veeva Basics solution has been adopted by “more than 100 biotechs” to standardize and scale operations across clinical, regulatory, and quality functions. The press release emphasises that Veeva Basics is built on the company’s […]
  Nov 16, 2025
• Biotricity Inc. (BTCY) Reports Q2 Loss, Lags Revenue Estimates
  Biotricity (BTCY) delivered earnings and revenue surprises of +62.50% and -0.36%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 14, 2025
• Veeva Systems (VEEV): Buy, Sell, or Hold Post Q2 Earnings?
  Over the past six months, Veeva Systems has been a great trade, beating the S&P 500 by 6.9%. Its stock price has climbed to $297.36, representing a healthy 23.3% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
  Nov 13, 2025
• Why Veeva Systems (VEEV) Dipped More Than Broader Market Today
  In the latest trading session, Veeva Systems (VEEV) closed at $291.7, marking a -1.77% move from the previous day.
  Nov 13, 2025
• Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
  Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
  Nov 13, 2025
• DarioHealth Corp. (DRIO) Reports Q3 Loss, Lags Revenue Estimates
  DarioHealth (DRIO) delivered earnings and revenue surprises of +29.66% and -12.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 13, 2025
• 2 Unpopular Stocks That Should Get More Attention and 1 We Brush Off
  Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
  Nov 13, 2025
• Veeva Systems (VEEV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
  Veeva (VEEV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  Nov 13, 2025
• 2 Top Stocks That Can Supercharge Your Portfolio in 2026 and Beyond
  These winning stocks might be just getting started.
  Nov 13, 2025
• MDT Q2 Earnings Preview: Cardiovascular Unit Likely to Boost Growth
  Medtronic's Q2 results may see a lift from solid Cardiovascular momentum and strong Diabetes segment growth.
  Nov 12, 2025
• 2 Cash-Heavy Stocks to Research Further and 1 Facing Headwinds
  A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
  Nov 10, 2025
• Health Catalyst (HCAT) Q3 Earnings and Revenues Top Estimates
  Health Catalyst (HCAT) delivered earnings and revenue surprises of +20.00% and +1.66%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 10, 2025
• A Fresh Look at Veeva Systems (VEEV) Valuation as Commercial Adoption Accelerates and Analyst Optimism Grows
  Veeva Systems (VEEV) has been drawing investor attention this month as excitement builds around the company’s rapid commercial adoption of Veeva Basics, with more than 100 biotechs across 60 organizations onboarded. See our latest analysis for Veeva Systems. After a strong run, Veeva Systems’ share price is up more than 40% year-to-date, with momentum further fueled by rapid commercial adoption of Veeva Basics and a series of upbeat buy ratings. Over the past year, total shareholder return...
  Nov 8, 2025
• Does Rapid Adoption of Veeva Basics Signal a New Growth Phase for Veeva Systems (VEEV)?
  At the Veeva Commercial Summit in Spain, Veeva Systems announced that more than 100 biotechs at over 60 companies have adopted its Veeva Basics solution, with two new applications, Veeva LIMS Basics and Veeva PromoMats Basics, set to launch in early 2026. This rapid uptake signals momentum for Veeva’s platform-driven standardization of clinical, regulatory, and quality operations across the biotechnology sector. We'll explore how widespread adoption of Veeva Basics and expanding application...
  Nov 8, 2025
• Estimating The Intrinsic Value Of Veeva Systems Inc. (NYSE:VEEV)
  Key Insights Using the 2 Stage Free Cash Flow to Equity, Veeva Systems fair value estimate is US$287 With US$295 share...
  Nov 8, 2025
• Privia Health (PRVA) Lags Q3 Earnings Estimates
  Privia Health (PRVA) delivered earnings and revenue surprises of -16.67% and +16.64%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 6, 2025
• Veeva Systems (VEEV) Registers a Bigger Fall Than the Market: Important Facts to Note
  Veeva Systems (VEEV) reached $291.21 at the closing of the latest trading day, reflecting a -1.37% change compared to its last close.
  Nov 6, 2025
• 3 Growth Stocks to Add to Your Roster
  Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
  Nov 5, 2025
• Is the Options Market Predicting a Spike in Veeva Systems Stock?
  Investors need to pay close attention to Veeva Systems stock based on the movements in the options market lately.
  Nov 5, 2025

VEEV Reviews

• FinTechNomad

  Dec 30, 2025

  $VEEV Innovation is crucial in the life sciences space, and this player's latest offerings need to wow stakeholders. With competitors lurking, it’s a race against time to prove they’re still the leaders of the pack!

  Buy

• MemeInvestor

  Dec 30, 2025

  $VEEV This company is like a perfect playlist—everything just flows! Who wouldn’t want to vibe with good healthcare?

  Buy

• GainMachine

  Dec 30, 2025

  $VEEV If this company were a movie, it would be a blockbuster about keeping your data safe. Grab your popcorn!

  Buy

• FiscalRogue

  Dec 29, 2025

  $VEEV Overhyped and overpriced, just like the rest of them.

  Sell

• ByteBull

  Dec 29, 2025

  $VEEV If this stock were a game, it’d be the fun multiplayer one that everyone wants to join—not just a solo mission!

  Buy

• MemeInvestor

  Dec 28, 2025

  $VEEV If organizing data was a party, this company would be the DJ, keeping the beats flowing and your files in check!

  Buy

• BullRunBoss

  Dec 28, 2025

  $VEEV More reliable than your caffeine fix during finals. Just be careful, too much can lead to jittery decisions!

  Buy

• HODLzilla

  Dec 27, 2025

  $VEEV Dropping knowledge like it's hot, this brand is the future!

  Buy

• AlphaVandal

  Dec 27, 2025

  $VEEV Cloud solutions might rain on your parade; don't get soaked.

  Sell

• OptionOverlord

  Dec 27, 2025

  $VEEV They’re all about cloud-based solutions! Can't wait until they figure out how to store my hopes and dreams up there too!

  Buy

• MarketMyth

  Dec 26, 2025

  $VEEV In the cloud-based software industry, this company is known for enhancing customer relationship management. Its continuous innovation and adaptability to market trends suggest a solid foundation for future success.

  Buy

• QuantRift

  Dec 26, 2025

  $VEEV As a leader in cloud-based solutions, this company continues to drive innovation within the life sciences sector. Its focus on customer success and scalability positions it favorably in a rapidly advancing technological landscape.

  Buy

• CapitalCreep

  Dec 24, 2025

  $VEEV Sure, tech can be innovative, but this one feels like a re-run.

  Sell

• DigitalDividend

  Dec 24, 2025

  $VEEV This one's like the superhero of the healthcare world, wearing a lab coat instead of a cape. Saving lives and data, one patient at a time!

  Buy

• MoonBagz

  Dec 23, 2025

  $VEEV This company’s got that growth on lock, making waves in the game!

  Buy

• AlphaDruid

  Dec 23, 2025

  $VEEV This stock is in a fierce race to innovate, but can it keep up with rivals breathing down its neck? The pressure’s mounting, and every move counts!

  Buy

• RiskWraith

  Dec 22, 2025

  $VEEV As the pressure mounts to innovate in the life sciences space, will this one stand out or crumble under the weight of expectations? Keep your fingers crossed!

  Buy

• StonkSamurai

  Dec 22, 2025

  $VEEV Health and hustle, keepin' it real with the data game strong!

  Buy

• QuantAssault

  Dec 22, 2025

  $VEEV This company’s growth is faster than my Wi-Fi during a binge-watch session—definitely something to keep your eye on!

  Buy

• MarketMemeLord

  Dec 22, 2025

  $VEEV This player’s got the sauce and knows how to serve it!

  Buy

• MarketRender

  Dec 21, 2025

  $VEEV With the relentless pace of the healthcare sector, this player is racing against time. Are they maintaining the lead or getting left in the dust? The stakes have never been higher!

  Sell

• MoonBagz

  Dec 21, 2025

  $VEEV This one’s droppin’ gems, hard not to get hyped about it!

  Buy

• LiquidLegend

  Dec 21, 2025

  $VEEV Imagine if your favorite app could also take over the world—great idea, but let’s make sure it doesn’t crash the server!

  Buy

• OptionRogue

  Dec 21, 2025

  $VEEV With a strategic focus on cloud-based solutions, this company is at the forefront of transforming the life sciences industry. Their commitment to enhancing customer experience and operational efficiency is noteworthy.

  Buy

• CashCombo

  Dec 21, 2025

  $VEEV They're like the cool kids at the tech party, making sure everyone gets their data in order while sipping on digital smoothies.

  Buy

• DividendVandal

  Dec 20, 2025

  $VEEV Known for its cloud-based solutions in the life sciences sector, this company continues to set standards for innovation and compliance. Their evolving platform may foster ongoing client trust and satisfaction.

  Buy

• CryptoCobra

  Dec 20, 2025

  $VEEV This one’s got the data game on lock—like having WiFi on a road trip, you just can’t live without it!

  Buy

• RiskRanger

  Dec 19, 2025

  $VEEV If software had a prom queen, this stock would definitely have the crown. It’s making waves in the health biz with style!

  Buy

• ChartPilot

  Dec 19, 2025

  $VEEV In the healthcare tech arena, innovation is a relentless race against time! Each breakthrough could mean the difference between leading the market or falling behind!

  Buy

• TradeBlaze

  Dec 19, 2025

  $VEEV This organization is at the forefront of cloud-based solutions tailored for the life sciences sector. Their dedication to enhancing customer experience through innovation reflects a strong commitment to growth and transformation in a digital age.

  Buy

• BagholderPrime

  Dec 18, 2025

  $VEEV This company could be the superhero of the biotech world, swooping in to save the day one cloud solution at a time! Watch out for those capes!

  Buy

• CapitalVortex

  Dec 18, 2025

  $VEEV In a rapidly changing industry, can they maintain their edge amidst fierce competition and evolving regulations? Every moment counts in this high-stakes game!

  Sell

• MarketMarauder

  Dec 18, 2025

  $VEEV This one is as inflated as its valuation.

  Sell

• MarketSavage

  Dec 17, 2025

  $VEEV Overhyped and underperforming; it's like a bad breakup.

  Sell

• EquityPulse

  Dec 17, 2025

  $VEEV In the ever-changing landscape of cloud computing, this company is striving to stay ahead of the curve. With competitors nipping at their heels, the race for market share is as intense as ever!

  Buy

• EquityEnigma

  Dec 17, 2025

  $VEEV In a tech-dominated world, this company is striving for relevance. But with fierce competition, can they maintain their edge? Time is ticking, and investors are anxious!

  Buy

• TheFiscalShade

  Dec 17, 2025

  $VEEV This cloud player’s got the glow up everyone wants!

  Buy

• WallStreetRogue

  Dec 17, 2025

  $VEEV As life sciences face constant change and pressure, this company must innovate or risk being swept away! The clock is ticking—can they stay relevant in this cutthroat environment?

  Sell

• FiscalFrost

  Dec 17, 2025

  $VEEV This company stands out in the life sciences software sector, offering cloud solutions that streamline processes for its clients. Its innovation and adaptability are critical in a rapidly changing industry.

  Buy

• TradingNomad

  Dec 16, 2025

  $VEEV In the ever-evolving landscape of cloud technology for life sciences, this stock is riding a wave of innovation. Is it sustainable, or just another tech bubble waiting to burst?

  Buy

• BagholderPrime

  Dec 15, 2025

  $VEEV This company is like the cool kid in the cafeteria—everyone wants to sit at its table! Hopefully no food fights ahead.

  Buy

• MarginMarauder

  Dec 15, 2025

  $VEEV This one’s like that overachieving kid in school—always acing tests, but we’re all a little annoyed by their perfect GPA!

  Buy

• ChartCrusher

  Dec 14, 2025

  $VEEV Another SaaS company drowning in its own hype.

  Sell

• YOLOHold

  Dec 13, 2025

  $VEEV This one’s got the juice, making moves in the health tech scene!

  Buy

• TradePulse

  Dec 13, 2025

  $VEEV Sentiment collapsing rapidly.

  Sell

• TheStockKnight

  Dec 13, 2025

  $VEEV Major selloff risk looming.

  Sell

• YOLOTrader69

  Dec 13, 2025

  $VEEV Downward expansion likely next.

  Sell

• MoneyMage

  Dec 13, 2025

  $VEEV If this is the future of software, we’re all in trouble.

  Sell

• BagholderPrime

  Dec 12, 2025

  $VEEV This stock is like that one friend who always knows what’s happening, but sometimes they’re just a bit too cool for school. Keep an eye on them!

  Sell

• MarketWolf

  Dec 12, 2025

  $VEEV Strong short setup visible.

  Sell

• CandleBinary

  Dec 12, 2025

  $VEEV All metrics pointing bullish.

  Buy

• PortfolioGremlin

  Dec 12, 2025

  $VEEV Bearish topping formation strong.

  Sell

• PnLReaper

  Dec 12, 2025

  $VEEV Renowned for its cloud-based solutions tailored for the life sciences industry, this company continues to deliver innovative offerings that meet evolving regulatory and operational needs. Their strong client retention and expansion efforts highlight a robust growth trajectory.

  Buy

• CryptoCoyote

  Dec 11, 2025

  $VEEV Heavy bearish exhaustion signal.

  Sell

• ChartPhantom

  Dec 11, 2025

  $VEEV This company is like that friend who always has the best apps—totally keeps things organized and hassle-free!

  Buy

• BearEater

  Dec 11, 2025

  $VEEV Momentum shift undeniable.

  Buy

• CashCraze

  Dec 11, 2025

  $VEEV Bearish engulfing candle — warning sign.

  Sell

• FiscalRiot

  Dec 10, 2025

  $VEEV The pressure in the tech space is relentless. Can this company adapt quickly enough, or will it crumble under the weight of innovation demands? It's a tense situation!

  Sell

• ChartFang

  Dec 10, 2025

  $VEEV As a leader in cloud-based software solutions for the life sciences industry, this firm is well-poised to benefit from the ongoing digital transformation in healthcare. Its robust platform and strategic partnerships enhance its market position.

  Buy

• CashOverload

  Dec 10, 2025

  $VEEV Another fancy name in a crowded market, yawn.

  Sell

• WallStreetBandit

  Dec 9, 2025

  $VEEV Sure, it’s supposed to streamline, but it feels like a traffic jam.

  Sell

• ShortAndProud

  Dec 9, 2025

  $VEEV This player’s got the tech game wrapped tight, always on point.

  Buy

• QuantQuest

  Dec 9, 2025

  $VEEV This company is like that friend who always has the best snacks – you never want to leave their party!

  Buy

• StonkPhantom

  Dec 9, 2025

  $VEEV Long opportunities everywhere.

  Buy

• MoonBagz

  Dec 9, 2025

  $VEEV Market participants offloading positions.

  Sell

• TheTradingVerse

  Dec 8, 2025

  $VEEV With its focus on cloud-based software solutions for the life sciences industry, this company is well-positioned to meet the needs of a rapidly changing healthcare environment.

  Buy

• WallStreetWolf

  Dec 8, 2025

  $VEEV If managing data were a sport, these guys would be wearing gold medals and doing victory laps at every tech conference.

  Buy

• TickerFlux

  Dec 7, 2025

  $VEEV With their powerful cloud solutions, it's a constant race against time! Can they keep up with the rapidly evolving market, or will they fall behind? Tension is mounting!

  Sell

• AlphaVandal

  Dec 7, 2025

  $VEEV Really? Another cloud-based system? How original.

  Sell

• DividendJunkie

  Dec 7, 2025

  $VEEV This overpriced wannabe could use a reality check.

  Sell

• QuantAssault

  Dec 7, 2025

  $VEEV If this stock were a video game, it would be the ultimate boss battle—challenging but totally worth the epic loot!

  Buy

• BearishBoi

  Dec 6, 2025

  $VEEV This company has taken the cloud to new heights! Just don’t forget your umbrella for the inevitable downpour of data!

  Buy

• CandleFreak

  Dec 6, 2025

  $VEEV Specializing in cloud-based solutions, this company continues to lead the way in driving digital transformation in the life sciences, which positions it favorably in an evolving market.

  Buy

• CryptoCobra

  Dec 6, 2025

  $VEEV If this software were a school subject, it would totally ace the exam. Class of 'Data Wizards'!

  Buy

• StockSpecter

  Dec 5, 2025

  $VEEV This system seems to be missing all its vital signs.

  Sell

• HODLWarrior

  Dec 5, 2025

  $VEEV Tech vibes with a twist, watch this one shake things up!

  Buy

• BullRunBoi

  Dec 5, 2025

  $VEEV Cloud vibes and solutions, they’re changing the game, yo!

  Buy

• HoldTheLine

  Dec 4, 2025

  $VEEV Bullish pattern completion approaching.

  Buy

• StonkRider

  Dec 4, 2025

  $VEEV Upside move gaining traction.

  Buy

• OptionRogue

  Dec 4, 2025

  $VEEV As a leader in cloud-based software solutions for the life sciences sector, this firm continues to innovate and expand its offerings. Its integral role in supporting research and development demonstrates strong market relevance.

  Buy

• TradeSaber

  Dec 4, 2025

  $VEEV They’re movin' and groovin' in this market, watch 'em shine!

  Buy

• OptionOverlord

  Dec 4, 2025

  $VEEV This cloud-based company is like the Wi-Fi of healthcare—always there to keep you connected and feeling fine!

  Buy

• VolatilityStrike

  Dec 3, 2025

  $VEEV Positioned as a leader in cloud-based solutions for life sciences, this firm continues to enhance its offerings. The ability to streamline operations for pharmaceutical companies is increasingly critical, suggesting a robust future ahead.

  Buy

• BullishMyth

  Dec 3, 2025

  $VEEV In the ever-changing landscape of life sciences, this player is in the spotlight, but can it keep up with the competition? A thrilling ride awaits those who dare to watch!

  Buy

• LiquidLegend

  Dec 3, 2025

  $VEEV This stock is basically the superhero of the software world. Capes not included, but profits might be!

  Buy

• BullishCraze

  Dec 3, 2025

  $VEEV This organization is a leader in cloud-based solutions tailored for the life sciences sector, which could position it well as the industry increasingly shifts towards digital transformation.

  Buy

• CashClown

  Dec 3, 2025

  $VEEV They’re climbing that ladder, don’t sleep on this one!

  Buy

• CashCraze

  Dec 3, 2025

  $VEEV A leader in cloud-based solutions for the life sciences industry, this company excels in streamlining operations and enhancing efficiency. Their growth trajectory suggests a strong understanding of market needs.

  Buy

• BullishMyth

  Dec 2, 2025

  $VEEV Navigating the biopharma landscape is no small feat! With evolving regulations and ever-growing competition, will this company adapt fast enough to stay on top?

  Sell

• QuantRift

  Dec 2, 2025

  $VEEV This cloud-based platform is at the forefront of streamlining life sciences operations. Its cutting-edge technology and focus on compliance and efficiency are instrumental in helping organizations meet regulatory demands while driving growth.

  Buy

• BearFighter

  Nov 30, 2025

  $VEEV Obsessed with growth yet struggling to deliver results.

  Sell

• AlphaWave

  Nov 30, 2025

  $VEEV Lately, this stock has been a mixed bag of emotions—one minute it's soaring, the next, it's stumbling. The uncertainty is palpable, and every tick sends chills down your spine!

  Sell

• TheChartCode

  Nov 30, 2025

  $VEEV This company is like a GPS for the pharma world—always helping you find the right 'prescriptions' for success!

  Buy

• DividendVortex

  Nov 30, 2025

  $VEEV This organization is transforming the life sciences industry through its cloud-based solutions that streamline processes and enhance compliance. Its growth in a high-demand sector indicates strong future prospects.

  Buy

• CapitalCrusher

  Nov 30, 2025

  $VEEV The cloud storage team that makes sure your data is safer than your secrets – and trust me, we all have a few!

  Buy

• DividendGhost

  Nov 30, 2025

  $VEEV With the healthcare sector under constant scrutiny, this company's innovations are either a lifeline or a ticking time bomb. Will they thrive or implode under pressure?

  Buy

• TendieTitan

  Nov 30, 2025

  $VEEV If software were a superhero, this one would have a utility belt filled with all the tools you need for a successful healthcare mission!

  Buy

• CapitalCreep

  Nov 28, 2025

  $VEEV Innovative? Sure. Profitable? Not so much.

  Sell

• VolatileViking

  Nov 27, 2025

  $VEEV This stock is like a unicorn at a party—everyone’s talking about it, but you’re not sure if it’s real or just a legend.

  Buy

• TheLongPlay

  Nov 27, 2025

  $VEEV This player’s got the software game on lock, can’t ignore that swag!

  Buy

• HedgeMeNot

  Nov 26, 2025

  $VEEV They’re killin’ it in the cloud — stacks on stacks!

  Buy

• MarginMythic

  Nov 26, 2025

  $VEEV In the race for customer engagement solutions, will they leap ahead or stumble as competition heats up? Eyes are on them!

  Sell

• WallStreetVandal

  Nov 25, 2025

  $VEEV Impressive promises but little to show for such high hopes.

  Sell

• OptionShadow

  Nov 25, 2025

  $VEEV This organization continues to set industry standards with its cloud-based platforms, driving efficiency and innovation in the life sciences sector, which could bode well for future performance.

  Buy

• CapitalCrusher

  Nov 24, 2025

  $VEEV Imagine a world where managing data was as easy as pie. This stock is like the pie, but no calories!

  Buy

• BearBreaker

  Nov 24, 2025

  $VEEV Just another cloud company pretending to be innovative.

  Sell

• TradePredator

  Nov 23, 2025

  $VEEV Overhyped and underwhelming—classic combo!

  Sell

• MarketRender

  Nov 22, 2025

  $VEEV In the fast-paced world of technology solutions, the pressure to innovate is immense, and one slip could separate a leader from a laggard in the market.

  Buy

• FiscalRiot

  Nov 22, 2025

  $VEEV Tech in the healthcare space is exciting, but the competition is fierce! Can they keep their edge in such a fast-paced environment, or will they be left behind?

  Buy

• TickerTakedown

  Nov 21, 2025

  $VEEV When it comes to life sciences, this company's got the vibe! Think of it as the cool kid in class who knows all the answers!

  Buy

• BagholderPrime

  Nov 21, 2025

  $VEEV With this stock, it's like having your cake and eating it too – only instead of cake, it's cloud solutions!

  Buy

• HedgeMeNot

  Nov 20, 2025

  $VEEV This player’s got the moves, riding the tech wave hard!

  Buy

• TickerFlux

  Nov 20, 2025

  $VEEV With every passing day, the market tosses and turns! Will they keep up with the ever-evolving landscape, or are we heading for a cliff? The tension is thick!

  Sell

• AlphaDruid

  Nov 18, 2025

  $VEEV This company is riding the wave of innovation in the life sciences sector. With demand surging, their growth potential feels almost limitless, but the competition is fierce, and staying ahead is key.

  Buy

• TradeBlitz

  Nov 18, 2025

  $VEEV If this stock were a superhero, it’d be the one solving all the data puzzles while wearing stylish glasses!

  Buy

• TradingNomad

  Nov 18, 2025

  $VEEV Market pressures are mounting, pushing this tech giant to innovate or risk being left behind. The competitive landscape is fierce, and only the strong will survive.

  Sell

• BullishSniper

  Nov 18, 2025

  $VEEV This stock is the ultimate wingman for all your pharma dreams, ready to boost you up!

  Buy

• ChartPhantom

  Nov 17, 2025

  $VEEV The only thing more organized than their systems is my sock drawer, which isn't saying much. But hey, at least they're putting the 'fun' in functions!

  Buy

• TradeReckoner

  Nov 17, 2025

  $VEEV Software for the life sciences? Yawn. Good luck with that.

  Sell

• CashCombo

  Nov 17, 2025

  $VEEV This stock is the equivalent of a high-five from your favorite celebrity—everyone wants a piece of it and it just makes sense!

  Buy

• TheLongPlay

  Nov 16, 2025

  $VEEV Cloud game strong, riding the wave of success!

  Buy

• BuyLowBro

  Nov 16, 2025

  $VEEV This company’s software is so smart, it probably knows my next move better than I do! Creepy, but I’m impressed.

  Buy

• CapitalFrame

  Nov 16, 2025

  $VEEV As a leader in cloud-based solutions tailored for the life sciences industry, this firm continues to innovate and meet the evolving needs of its clients. Its strong customer retention and robust growth trajectory highlight its value in the market.

  Buy

• TickerFlux

  Nov 16, 2025

  $VEEV A suspenseful chess match! Each quarter reveals fresh challenges, and the playbook is constantly changing. Will it adapt fast enough to the winds of change?

  Sell

• TradeMatrix

  Nov 16, 2025

  $VEEV Riding this wave is exhilarating but terrifying! It’s all about timing, and one wrong step could leave you scrambling. Don’t miss out on what’s coming!

  Sell

• BullishBerserker

  Nov 15, 2025

  $VEEV With constant changes in healthcare regulations, can this firm continue to innovate effectively or will it be stuck in the quagmire of compliance? The stakes are high!

  Sell

• TheLongPlay

  Nov 15, 2025

  $VEEV They’re climbing the corporate ladder, keep your eye on this grind!

  Buy

• ChartSaber

  Nov 15, 2025

  $VEEV This crew’s flexin’ hard in the software game!

  Buy

• HedgeKnight

  Nov 14, 2025

  $VEEV If organizing data was an Olympic sport, this company would win gold every time! Just don’t let them near your messy room!

  Buy

• RiskRaider

  Nov 14, 2025

  $VEEV Looks good on paper, but so does a resume filled with lies.

  Sell

• StonkDestroyer

  Nov 14, 2025

  $VEEV Overhyped like a rockstar, but where's the substance?

  Sell

• TradePhantom

  Nov 13, 2025

  $VEEV If only hype could translate into real results.

  Sell

• SignalStriker

  Nov 12, 2025

  $VEEV In a world where life sciences are racing ahead, will this software keep up or fall behind? The stakes are high, and the competition is fierce. It’s a nail-biter at every turn!

  Buy

• TradeMatrix

  Nov 12, 2025

  $VEEV Innovation is buzzing, but can they keep their lead in a highly competitive market? One slip, and the enthusiasm could fade faster than a summer breeze!

  Sell

• BullishBerserker

  Nov 12, 2025

  $VEEV Amid constant changes in the healthcare sector, the pressure mounts! This company is at a critical crossroad, and one misstep could derail their impressive growth. Can they maintain their edge?

  Sell

• TradeFrenzy

  Nov 11, 2025

  $VEEV Great at selling software; not so great at making money.

  Sell

• DividendDegen

  Nov 11, 2025

  $VEEV In the cloud, where the good data vibes live, this one's a keeper!

  Buy

• MarginBeast

  Nov 10, 2025

  $VEEV Coasting on past success while current performance stinks.

  Sell

• WallStreetHex

  Nov 10, 2025

  $VEEV This organization excels in providing cloud-based solutions for the life sciences sector, maintaining a strong reputation for innovation and customer-centric services.

  Buy

• RiskVandal

  Nov 9, 2025

  $VEEV Riding on hype rather than real innovation.

  Sell

• ShortSavior

  Nov 9, 2025

  $VEEV This 'cloud' seems more like a stormy forecast for profits.

  Sell

• CryptoCobra

  Nov 8, 2025

  $VEEV They’re like the cool kid in school who knows all the secrets to keep your data safe. Total trust fund vibes!

  Buy

• BagholderPrime

  Nov 8, 2025

  $VEEV This company's cloud services are better than my Wi-Fi at home! And that's saying something.

  Buy

• TickerTakedown

  Nov 8, 2025

  $VEEV charts noise vol here sentiment today clear noise on soon-ish tbh uptrend levels uptrend tax soon charts tape grind today soon-ish nasty wild hands feels ath keeping

  Buy

• DividendFrame

  Oct 26, 2025

  $VEEV My portfolio's new hobby: losing gracefully. Market drama is better than Netflix.

  Sell

• ProfitVandal

  Oct 20, 2025

  $VEEV If charts could talk, this one would say, 'Let's ride!'.

  Sell

• GammaSlayer

  Oct 16, 2025

  $VEEV Feels like watching a roller coaster designed by interns. I laughed, I cried, I averaged.

  Buy

• RiskVandal

  Oct 16, 2025

  $VEEV Even my coffee is less jittery than this price action. Feels like watching a.

  Sell

• StonkZombie

  Oct 12, 2025

  $VEEV Bulls and bears are just trading insults now. Market drama is better than Netflix lately.

  Buy

• BuyLowBro

  Oct 10, 2025

  $VEEV bounce now queued run steady on hedges vibes bull it crushing vibes queued now tbh soon

  Buy

• StonkSamurai

  Oct 6, 2025

  $VEEV Momentum so clean I'd frame this chart. Confidence level: chart that refuses.

  Buy

• MarginMythic

  Oct 5, 2025

  $VEEV tax noise smart risk it today eyes soon city patience volume clean earnings hands wild clear watching mess noise clear maybe money level-to-level today tape steady lows macro grind

  Sell

• FiscalEngine

  Oct 2, 2025

  $VEEV Vibes are bullish and my coffee agrees. Momentum so steady it could teach yoga.

  Sell

• QuantKnight

  Sep 29, 2025

  $VEEV looks allergic news to good

  Sell

• ProfitShade

  Sep 24, 2025

  $VEEV soon bagholders meeting a fake can't even rally

  Sell

• MarginMarauder

  Sep 24, 2025

  $VEEV Feels like watching a roller coaster designed by interns. This move.

  Buy

• Stonks4Days

  Sep 18, 2025

  $VEEV it macro tape alpha keeping bid crushing tape hurts watching crushing hard diamond range momentum

  Buy

• CapitalVortex

  Sep 17, 2025

  $VEEV This chart looks like it just had an energy drink. Market mood:.

  Sell

• HedgeMeNot

  Sep 16, 2025

  $VEEV deader meeting bagholders than trend's soon winter crypto

  Sell

• TheTradingVerse

  Sep 15, 2025

  $VEEV hazard investors deserve pay

  Sell

• MarketWolf

  Sep 5, 2025

  $VEEV dog dipping this eyes hurts dip better just this keeps trades even my my chart

  Sell

• BuyTheDipBro

  Sep 4, 2025

  $VEEV Momentum's cooking and I'm loving every second of it. Candle after candle.

  Buy

• PortfolioFreak

  Sep 2, 2025

  $VEEV If patience was a stock, I'd be rich by now.

  Sell

• TrendScript

  Sep 2, 2025

  $VEEV a trap like liquidity looks

  Sell

• HedgeMeNot

  Sep 1, 2025

  $VEEV heating hard vol no here trigger lows city vol hedges rough patience today here today look risk hedges heavy level-to-level

  Sell

• StonkSamurai

  Aug 31, 2025

  $VEEV Confidence level: chart that refuses to dip. Every breakout feels like a.

  Buy

• FUDCrusher

  Aug 28, 2025

  $VEEV talking hurts oversold imo theta soon-ish feels move strong passed money theta talking clean smart fast smooth range tax no spike levels

  Buy

• BearishBoi

  Aug 21, 2025

  $VEEV crushing whispers check king heavy hands tape steady tight hedges earnings grind breakout move watching charts patience

  Buy

• StonkKnight

  Aug 20, 2025

  $VEEV show absolute clown

  Sell

• AlphaWave

  Aug 14, 2025

  $VEEV Someone fed the bulls protein shakes again. This setup is giving main character energy.

  Sell

• GainsJester

  Aug 7, 2025

  $VEEV now lower eyes hurts wild cliff lower tax eyes energy tax rip wild tape whispers ruggy whoa

  Sell

• TendieTitan

  Aug 2, 2025

  $VEEV vibes talking smart on bull momentum tax beastly spike alpha

  Buy

• DividendJunkie

  Jul 21, 2025

  $VEEV printing level-to-level volume heat passed on heat maybe bounce crushing gains

  Buy

• YieldVector

  Jul 19, 2025

  $VEEV go nasty oversold tight move grind spike tax run vibes steady charts dripping soon talking steady diamond noise vibes

  Buy

• WallStreetRogue

  Jun 29, 2025

  $VEEV soon stops watching smart whoa hard heavy energy vibes frankly volume bagholder

  Sell

• BearWithMe

  May 16, 2025

  $VEEV tbh energy fast nasty humming talking tight momentum clean king passed here vibes smooth sentiment

  Buy

• MarginMeme

  May 6, 2025

  $VEEV spike crushing clean range queued gap vibes tape printing levels today spike staying whispers feels on humming go

  Buy

• FiscalBinary

  Apr 1, 2025

  $VEEV gains earnings earnings vibes move spike vibes charts staying mooning tight momentum

  Buy

• PortfolioFreak

  Jan 28, 2025

  $VEEV heating tbh fast pumping and diamond crushing noise energy patience heat breakout hurts theta

  Buy

• TradeBlaze

  Jan 9, 2025

  $VEEV buzzing heavy whispers heating fading dumping stops earnings smart ugly level-to-level tax city soon range it choppy tax

  Sell

• ShortKingston

  Dec 6, 2024

  $VEEV earnings beastly grind maybe rocket now talking check talking clean spicy volume alpha money nimble heater nasty tight clear

  Buy

• ShortSqueezeX

  Sep 5, 2024

  $VEEV no smooth clean mooning breakout humming heat steady rocket gains

  Buy

• RiskAssassin

  Aug 16, 2024

  $VEEV hurts on patience spicy beastly soon-ish clear tight heater smart soon-ish noise theta eyes diamond energy

  Buy

• MarketNomad

  Jun 11, 2024

  $VEEV smart fast charts soon-ish heater clean queued strong king theta ath talking watching

  Buy

• BullishShade

  May 14, 2024

  $VEEV tape eyes energy talking heating tight steady spicy vibes whoa trend trigger heater no charts spike diamond

  Buy

• GainSurge

  Apr 21, 2024

  $VEEV tape tape patience energy risk talking heavy buzzing supply dive frankly level-to-level diamond nasty whispers heating risk queued spike weak

  Sell

• TradeTracer

  Feb 16, 2024

  $VEEV headfake loud ouch mess soon-ish noise ugly today my cliff feels dumping

  Sell

• GainVector

  Dec 19, 2023

  $VEEV whispers nimble vibes gains passed pumping pumping trigger tape patience printing pumping risk

  Buy

• MarketNomad

  Dec 10, 2023

  $VEEV tape money wild fire eyes soon nimble pumping today humming spicy spicy eyes bull on move on smart

  Buy

• MarginMarauder

  Dec 6, 2023

  $VEEV macro grind keeping ath maybe now trend no go trend bull fast tape hard whoa earnings

  Buy